DK1448772T3 - Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor - Google Patents

Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor

Info

Publication number
DK1448772T3
DK1448772T3 DK02777356T DK02777356T DK1448772T3 DK 1448772 T3 DK1448772 T3 DK 1448772T3 DK 02777356 T DK02777356 T DK 02777356T DK 02777356 T DK02777356 T DK 02777356T DK 1448772 T3 DK1448772 T3 DK 1448772T3
Authority
DK
Denmark
Prior art keywords
methods
amino acid
expression levels
proline
tnf receptor
Prior art date
Application number
DK02777356T
Other languages
Danish (da)
English (en)
Inventor
William Brondyk
Xuliang Jiang
Rene Lynn Schweickhardt
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of DK1448772T3 publication Critical patent/DK1448772T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK02777356T 2001-11-30 2002-11-21 Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor DK1448772T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
PCT/EP2002/013059 WO2003046160A2 (en) 2001-11-30 2002-11-21 Methods of increasing protein expression levels

Publications (1)

Publication Number Publication Date
DK1448772T3 true DK1448772T3 (da) 2007-11-19

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02777356T DK1448772T3 (da) 2001-11-30 2002-11-21 Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor

Country Status (12)

Country Link
US (2) US7258997B2 (enExample)
EP (1) EP1448772B1 (enExample)
JP (1) JP2005535281A (enExample)
AT (1) ATE367438T1 (enExample)
AU (1) AU2002338947B2 (enExample)
CA (1) CA2466298A1 (enExample)
DE (1) DE60221273D1 (enExample)
DK (1) DK1448772T3 (enExample)
ES (1) ES2290337T3 (enExample)
IL (1) IL162133A0 (enExample)
PT (1) PT1448772E (enExample)
WO (1) WO2003046160A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels
WO2005063813A2 (en) * 2003-12-23 2005-07-14 Applied Research Systems Ars Holding N.V. Process for the production of tumor necrosis factor-binding proteins
US8722348B2 (en) * 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
PT2705143T (pt) 2011-05-02 2021-04-07 Univ Wayne State Tecnologia de células pluripotentes induzidas por proteínas e utilizações da mesma
KR102113829B1 (ko) 2013-10-25 2020-05-25 웨인 스테이트 유니버시티 단백질-유도 생체내 세포 재프로그래밍을 통한 세포 전환 방법, 시스템 및 조성물
CA3144637A1 (en) * 2019-06-21 2020-12-24 Kernal Biologics, Inc. Engineered oncoselective protein expression
JP2023522534A (ja) * 2020-02-03 2023-05-31 プレマス バイオテック プライベート リミテッド 発現が困難なタンパク質を発現させるための、組換え発現プラットフォーム、構築物、および方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010941D1 (de) 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
EP0614353A1 (en) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
IL107268A0 (en) 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
WO2002094864A2 (en) * 2001-05-25 2002-11-28 Genset S.A. Human cdnas and proteins and uses thereof
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels

Also Published As

Publication number Publication date
CA2466298A1 (en) 2003-06-05
US7258997B2 (en) 2007-08-21
IL162133A0 (en) 2005-11-20
ES2290337T3 (es) 2008-02-16
AU2002338947B2 (en) 2007-09-13
US20080014635A1 (en) 2008-01-17
DE60221273D1 (de) 2007-08-30
EP1448772B1 (en) 2007-07-18
PT1448772E (pt) 2007-10-02
AU2002338947A1 (en) 2003-06-10
US20050074840A1 (en) 2005-04-07
ATE367438T1 (de) 2007-08-15
EP1448772A2 (en) 2004-08-25
WO2003046160A2 (en) 2003-06-05
WO2003046160A3 (en) 2003-07-31
JP2005535281A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
ATE417595T1 (de) Keratin-bindende polypeptide
PL1767546T3 (pl) Hamujące angiogenezę białka chimeryczne i ich zastosowanie
PE20061115A1 (es) Anticuerpos anti-il-12, epitopos, composiciones, metodos y usos
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
CO5690612A2 (es) Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos
WO2002020767A3 (en) G-csf analog compositions and methods
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
PL369739A1 (en) Modified anti-tnf alpha antibody
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
WO2002002627A3 (en) Interferon-like protein zcyto21
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
IL171356A (en) Anti-interferon receptor antibody for treatment of inflammatory bowel disease
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
DK1383874T3 (da) Varianter af lipogygenase og deres anvendelse
AR039629A1 (es) Antagonistas de proteinas mcp
ATE367438T1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
WO2003012053A8 (en) Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis
WO2000058465A3 (en) Flint polypeptide analogs
NO20025152D0 (no) EDG8-reseptor, dens fremstilling og anvendelse
EP1978994A4 (en) BMP-7 VARIANTS COMPOSITIONS, METHODS AND USES
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
JP2005535281A5 (enExample)
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
ATE358682T1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2